Valerie is an innovative startup focused on transforming women's healthcare during the crucial phases of peri/menopause, a market affecting over 1 billion women globally. Founded in 2024, the company is spearheading a movement to empower women with science-backed solutions, embodied in their slogan, "Liberating women to live fully & freely."
The company offers a flagship product, the Daily Essential, which utilizes pioneering liposomal nanotechnology to deliver 90 health benefits, encapsulating Valerie's commitment to delivering more than traditional remedies. This approach offers women the opportunity to regain control over their health and well-being.
Receiving a £510.00K seed investment led by Giles Brook on 01 May 2025, Valerie is positioned for rapid growth. The company is backed by a mission to redefine midlife for women, marking it as a promising prospect for investors seeking to make a meaningful impact in the healthcare industry. This strategic funding provides a robust foundation to expand their vision and capitalize on the untapped market potential.
